STXS stock gains after first U.S. MAGiC procedures, marking a key milestone in robotic cardiac care and boosting its growth ...
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients in the US have been successfully treated ...
Stereotaxis (NYSE:STXS) today announced the first patients successfully treated in the U.S. with its MAGiC system.
Please provide your email address to receive an email when new articles are posted on . The FDA granted a new indication to a cryoballoon ablation catheter that allows it to be used as a first-line ...
First-line treatment with catheter ablation is superior to drug therapy for reducing atrial fibrillation, according to five year results from the MANTRA-PAF trial presented for the first time at ESC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results